Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 745–768 of 2,608 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Application Use Clear all

Conditions: IBS - Irritable Bowel Syndrome
Interventions: Use of Zemedy Application; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Redwood City, California

Conditions: HIV Infections
Interventions: Cabotegravir sodium (Oral Lead In), Cabotegravir 400 mg/mL, Cabotegravir 200 mg/mL, Topical Non-steroidal anti-inflammatory drug (NSAID), Topical steroid, Topical NSAID placebo, Recombinant human hyaluronidase PH20 (rHuPH20), Topical steroid placebo; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 138 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 4
States / cities: Orlando, Florida • Las Vegas, Nevada • Berlin, New Jersey + 1 more

Conditions: Post Traumatic Stress Disorder
Interventions: CPT Skills, Cognitive Processing Therapy, Present Centered Therapy, Shared Decision Making, Measurement Based Care; Behavioral
Lead sponsor: United States Department of Defense; Federal
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 4
States / cities: Phoenix, Arizona • New Orleans, Louisiana • Charleston, South Carolina + 1 more

Conditions: PTSD, Trauma
Interventions: Estradiol patch, Placebo patch; Drug · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Pediatric ALL, Cancer
Interventions: IPAD, Augmented Reality; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 5 Years to 15 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Anxiety
Interventions: Mayo Clinic Anxiety Coach; Device
Lead sponsor: Stephen Whiteside; Other
Eligibility: 7 Years to 17 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Interventions: Medical Device Usage and Evaluation, Survey Administration; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Pain, Anxiety
Interventions: Bluetooth Haptic Device (BHD), BHD synced with mobile game; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 4 Years to 99 Years
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Anxiety Disorders, Depression, Electronic Media
Interventions: Electronic Media Enhanced, Treatment as Usual; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 14 Years to 85 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Olfactory Dysfunction, Smell Loss, Anosmia, Hyposmia
Interventions: Sudoku Puzzles, ScentCare (Olfactory Training Device); Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 60 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cardiorespiratory Failure
Interventions: Coping skills training mobile app with call from CST therapist, Coping skills training mobile app only; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Depression, Major Depressive Disorder
Interventions: MoodTriggers Application; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Hanover, New Hampshire • Lebanon, New Hampshire

Conditions: Atrial Septal Defect
Interventions: Fluorescite, Cellvizio 100 Series System with Confocal Miniprobes; Drug · Device
Lead sponsor: Aditya Kaza; Other
Eligibility: 30 Days to 21 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Lesion Skin, Seborrheic Keratosis, Skin Lesion, Benign Skin Tumor
Interventions: Nano-Pulse Stimulation (NPS); Device
Lead sponsor: Pulse Biosciences, Inc.; Industry
Eligibility: 21 Years to 75 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 7
States / cities: Scottsdale, Arizona • Edwards, Colorado • Coral Gables, Florida + 4 more

Conditions: Nonverbal Communication, Critical Illness
Interventions: Aim 1 - VidaTalk - post-extubation, Aim 2 - VidaTalk - intubated, Aim 3 - VidaTalk tablet app, Aim 3 - attention-control with non-VidaTalk tablet; Other · Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hypoglycemia, Diabetes Mellitus, Type 1
Interventions: Vigilant Diabetes Management Application; Device
Lead sponsor: InSpark Technologies, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: Opioid Use
Interventions: Not applicable- observational study; Other
Lead sponsor: Tenvos Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Granuloma, Tracheostomy
Interventions: Betadine, Silver Nitrate, Hydrocortisone Butyrate Cream, 1.0%; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 31 Days to 17 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Peripheral Vascular Disease
Interventions: Cryoplasty (PolarCath peripheral balloon catheter), Laser Angioplasty (Spectranetics), SilverHawk Atherectomy, Viabahn Endograft, Angioplasty/Stent (Guidant "Absolute" stent); Procedure · Device
Lead sponsor: Arizona Heart Institute; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Diabetic Peripheral Neuropathy
Interventions: Skin biopsy, Lidocaine 5% patches; Procedure · Drug
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years to 70 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Albany, New York

Conditions: External Ventricular Drain, Intracranial Pressure
Interventions: Axium Steatlh Image Guidance, EVD placement; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 88 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Opioid Use Disorder, Poor Quality Sleep
Interventions: mHealth application and sleep health education, Simplified mHealth application and sleep health education; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Dementia, Alzheimer Type
Interventions: ABC Clinical Program, BCN; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Fibromyalgia
Interventions: Gabapentin, Osteopathic Manipulative Medicine, Gabapentin and Osteopathic Manipulative Medicine; Drug · Procedure · Other
Lead sponsor: Good Samaritan Regional Medical Center, Oregon; Other
Eligibility: 18 Years to 65 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Vallejo, California

Search by objective public record fields.

Zemedy Application for Irritable Bowel Syndrome

Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants

Reducing Dropout and Improving Outcomes From PTSD Therapy: When to Switch Therapies or Stay the Course

Neuroendocrine Risk for PTSD in Women

A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study)

Youth Mayo Clinic Anxiety Coach Pilot Study

Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General Anesthesia

Examining Bluetooth Haptic Device Use for Pain and Distress Reduction in Vascular Access Procedures

Electronic Media and Its Application in Psychotherapy

Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults

Mobile Coping Skills Training to Improve Cardiorespiratory Failure Survivors' Psychological Distress

Remote Evaluation and Alerting for Collaborative Health (REACH) in Depression

Utilization of Confocal Microscopy During Cardiac Surgery

Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study

Vidatalk Communication Application: Usability, Acceptability and Efficacy Study

A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion

Voice Technology to Identify Opioid Use

Treatment of Tracheostomy Granulomas

Prime Time for Superficial Femoral Artery (SFA) - The SFA Study

Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy

External Ventricular Drain Placement Stealth Study

Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD

Technology Intervention to Support Caregiving for Alzheimer's Disease (I-CARE)

Fibromyalgia Treatment Trial With Gabapentin and Osteopathic Manipulative Medicine